1 0

    FDA Communications to Teva Re: ANDA 076772 and 076655 (Feb-Apr 2019)

    FDA Communications to Teva Re: ANDA 076772 and 076655 (Feb-Apr 2019)

    $69.00 USD
    $69.00 USD
    Sale Sold out
    Original Request: 1. Copies of all written communications (including but not limited to emails and letters) sent from the FDA to Teva Pharmaceuticals, Inc. (“Teva”) during the time period from February 2, 2019 through April 24, 2019, relating to: a. ANDA Application No. 076772; and/or b. ANDA Application No. 076655. etc
    Tags: Pharma, ANDA, 2019
    • Status: Pending Fast-Track Request
    • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

    NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

    View full details